Quality of life and satisfaction with treatment in subjects with type 2 diabetes: Results in Spain of the PANORAMA study;Calidad de vida y satisfacción con el tratamiento de sujetos con diabetes tipo 2: Resultados en España del estudio PANORAMA

Endocrinologia y Nutricion

Volumn 61, Issue 1, 2014, Pages 18-26

  DePablos Velasco, Pedro ^a   Salguero Chaves, Emilio ^b   Mata Poyo, Julio ^c   DeRivas Otero, Beatriz ^d   García Sánchez, Ricardo ^e   Viguera Ester, Pablo ^d  

^a UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^b Servicio de Medicina Familiar y Comunitaria   (Spain)

^c Centro de Atención primaria de Tabara   (Spain)

^d ASTRAZENECA   (United Kingdom)

^e BRISTOL MYERS SQUIBB   (United States)

Author keywords

Quality of life; Treatment satisfaction; Type 2 diabetes mellitus

Indexed keywords

HEMOGLOBIN A1C; INSULIN; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DISEASE DURATION; HEALTH CARE PERSONNEL; HUMAN; HYPOGLYCEMIA; HYPOGLYCEMIA FEAR SURVEY; MAJOR CLINICAL STUDY; METABOLIC REGULATION; MONOTHERAPY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PATIENT SATISFACTION; QUALITY OF LIFE; SCORING SYSTEM; SPAIN; AGED; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIABETIC DIET; EUROPE; FEMALE; KINESIOTHERAPY; MALE; MIDDLE AGED; MOTOR ACTIVITY; MULTIMODALITY CANCER THERAPY; PATIENT COMPLIANCE; PSYCHOLOGY; QUESTIONNAIRE; RISK; VERY ELDERLY;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; DIET, DIABETIC; EUROPE; EXERCISE THERAPY; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MOTOR ACTIVITY; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUALITY OF LIFE; RISK; SPAIN; SURVEYS AND QUESTIONNAIRES;

EID: 84892550856     PISSN: 15750922     EISSN: 15792021     Source Type: Journal    
DOI: 10.1016/j.endonu.2013.05.005     Document Type: Article

References (30)

1. Soriguer F., Goday A., Bosch-Comas A., Bordiú E., Calle-Pascual A., Carmena R., et al. Prevalence of diabetes mellitus and impaired glucose regulation in Spain: the Diabeties Study. Diabetologia 2012, 55:88-93.
2. Ryden L., Standl M., Bartnik M., van der Berghe G., Betteridge J., de Boer M., et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 2007, 28:88-136.
3. Jönsson B. Revealing the cost of type II diabetes in Europe. Diabetologia 2002, 45(7S):S5-S12.
4. UK Prospective Diabetes Study Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352:854-865.
5. Holman R.R., Paul S.K., Bethel M.A., Matthews D.R., Neil A.W. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008, 359:1577-1589.
6. Gaede P., Lund-Andersen H., Parving H.H., Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008, 358:580-591.
7. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559. The Action to Control Cardiovascular Risk in Diabetes Study Group.
8. Patel A., MacMahon S., Chalmers J., Neal B., Billot L., Woodward M., et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008, 358:2560-2572. ADVANCE Collaborative Group.
9. Duckworth W., Abraira C., Moritz T., Reda D., Emanuele N., Reaven P.D., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360:129-139.
10. Algoritmo de tratamiento de la DM tipo 2. GEDAPS 2009. [consultado 13 Feb 2013] Disponible en: Última consulta (13/02/2013). http://www.redgdps.org/index.php%3Fidseccion=313.
11. Canadian Diabetes Association 2008 Clinical Practice Guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008, 32(Suppl 1):S1-S201. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee.
12. Standards of medical care in diabetes-2012. Diabetes Care 2012, 35(Suppl 1):S11-S63. American Diabetes Association.
13. Criado-Álvarez J.J., Méndez-Cabeza Fuentes J.C., Bustos Guadaño F. ¿Controlamos correctamente la diabetes desde atención primaria en Talavera de la Reina (Toledo)α Talavera de la Reina (Toledo), Spain (2006-2008). Semergen 2011, 37:113-128.
14. Franch Nadal J., Artola Menéndez S., Diez Espino J., Mata Cases M. The evolution of quality care indicators of patients with type 2 diabetes in the Spanish primary care (1996-2007). The RedGEDAPS quality of care program. Med Clin (Barc) 2010, 135:600-607. en representación de la Red de Grupos de Estudio de la Diabetes en Atención Primaria de la Salud.
15. De Pablos Velasco P., Franch Nadal J., Banegas Banegas J.R., Fernández Anaya S., Sicras Mainar A., Díaz Cerezo S., et al. Estudio epidemiológico del perfil clínico y control glucémico del paciente diabético atendido en centros de atención primaria en España (estudio EPIDIAP). Endocrinol Nutr 2009, 56:233-240.
16. Peyrot M., Rubin R.R., Lauritzen T., Skovlund S.E., Snoek F.J., Matthews D.R., et al. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005, 28:2673-2679.
17. Peyrot M., Rubin R.R., Siminerio L.M. Physician and nurse use of psychosocial strategies in diabetes care: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabetes Care 2006, 29:1256-1262.
18. de Pablos-Velasco P., Parhofer K.G., Bradley C., Eschwège E., Gönder-Frederick L., Maheux P., et al. Current level of glycaemic control and its associated factors in patients with type 2 diabetes across Europe: data from the PANORAMA study. Clin Endocrinol (Oxf) 2012, [Epub ahead of print]. 10.1111/cen.12119.
19. Bradley C., de Pablos-Velasco P., Parhofer K.G., Eschwège E., Gönder-Frederick L., Simon D. PANORAMA: a European study to evaluate quality of life and treatment satisfaction in patients with type-2 diabetes mellitus-study design. Prim Care Diabetes 2011, 5:231-239.
20. Bradley C., Todd C., Gorton T., Symonds E., Martin A., Plowright R. The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual Life Res 1999, 8:79-91.
21. Sánchez Lora F.J., Téllez Santana T., Gijón Trigueros A. Instrumentos específicos de medida de la calidad de vida relacionada con la salud en la diabetes mellitus tipo 2 disponibles en España. Med Clin (Barc) 2010, 35:658-664.
22. Cox D.J., Irvine A., Gonder-Frederick L., Nowacek G., Butterfield J. Fear of hypoglycemia: quantification, validation, and utilization. Diabetes Care 1987, 10:617-621.
23. Grandy S., Fox K.M. EQ-5D visual analog scale and utility index values in individuals with diabetes and a risk for diabetes: findings from the Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes (SHIELD). Health Qual Life Outcomes 2008, 6:18.
24. López-Simarro F., Brotons C., Moral I., Cols-Sagarra C., Selva A., Aguado-Jodar A., et al. Inercia y cumplimiento terapéutico en pacientes con diabetes mellitus tipo 2 en atención primaria. Med Clin (Barc) 2012, 138:377-384.
25. Pérez A., Franch J., Cases A., González Juanatey J.R., Conthe P., Gimeno E., et al. Relación del grado de control glucémico con las características de las diabetes y el tratamiento de la hiperglucemia en la diabetes tipo 2. Estudio DIABES. Med Clin (Barc) 2012, 138:505-511.
26. Conthe P., Mata M., Orozco D., Pajuelo F., Barreto C.S., Fernández Anaya S., Gomis R. Degree of control and delayed intensification of antihyperglycaemic treatment in type 2 diabetes mellitus patients in primary care in Spain. Diabetes Res Clin Pract 2011, 91:108-114.
27. Vinagre I., Mata-Cases M., Hermosilla E., Morros R., Fina F., Rosell M., et al. Control of glycemia and cardiovascular risk factors in patients with tyoe 2 diabetes in primary care in Catalonia (Spain). Diabetes Care 2012, 35:774-779.
28. Lundkvist J., Berne C., Bolinder B., Jonsson L. The economic and quality of life impact of hypoglycemia. Eur J Helath Econ 2005, 6:197-202.
29. Álvarez-Guisasola F., Yin D., Nocea G., Qiu Y., Mavros P. Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study. Health Qual Life Outcomes 2010, 8:86.
30. Álvarez-Guisasola F., Tofé Povedano S., Krishnarajah G., Lyu R., Mavros P., Yin D. Hypoglycaemic symptoms, treatment satisfaction, adherence ans their associations with glycaemic goal in patients with type 2 diabetes mellitus: finding from the real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. Diabetes Obes Metab 2008, 10(Suppl 1):25-32.